Imugene Buys Biolife Science

October 2013
Mergers & Acquisitions Report;10/28/2013, Vol. 28 Issue 43, p20
The article reports on the acquisition of cancer drug developer Biolife Science Qld Ltd. by pharmaceutical company Imugene.


Related Articles

  • III. TERMINATED MERGERS AND ACQUISITIONS.  // BioWorld Insight;12/2/2013, Vol. 21 Issue 49, p15 

    A table is presented which lists terminated mergers and acquisitions of global biotech companies as of December 2, 2013 including Acuvax Ltd., Biolife Science Ltd. and Transcept Pharmaceuticals Inc.

  • New lease of bio life. Haselhurst, David // Money (Australia Edition);May2013, Issue 156, p90 

    The article considers the potential of investing in the soon-to-be-relisted high-technology stock Biolife Science. The company's director and chief operating officer (COO) is Paul Hopper, while Roger Aston is executive chairman. Stockbroker Patersons Securities will manage the reconstruction of...

  • IMUGENE RECEPTOR MIMIC TECHNOLOGY PATENT GRANTED IN U.S.  // Worldwide Biotech;Mar2005, Vol. 17 Issue 3, p1 

    Reports on a patent granted by the U.S. to Imugene for its Receptor Mimic Technology through 2020. Importance of the technology to prevent the development of diarrhea in pigs; Ability of the receptor mimic product to bind toxins and bacteria which cause gastrointestinal diseases to mammals;...

  • II. PENDING MERGERS AND ACQUISITIONS.  // BioWorld Insight;4/1/2013, Vol. 21 Issue 14, p12 

    A chart is presented that lists U.S. biotechnology companies in pending mergers and acquisitions including 3SBio Inc., Aurinia Pharmaceuticals Inc., and Biolife Science Ltd.

  • II. PENDING MERGERS AND ACQUISITIONS.  // BioWorld Insight;12/2/2013, Vol. 21 Issue 49, p14 

    A table is presented which lists global biotech companies' pending mergers and acquisition as of December 2013 including Imugene Ltd., Perrigo Co. and Theraclone Sciences Inc.

  • Other News To Note.  // BioWorld International;3/20/2013, Vol. 18 Issue 12, p4 

    The article offers world news briefs related to the biotechnology industry as of March 20, 2013. Biolife Science Ltd. will be acquired by Acuvax Ltd. both based in Brisbane, Queensland. Ark Therapeutics Group Plc will not be for sale in connection with the City Code on Takeovers and Mergers in...

  • Unraveling the ramifications of recent pharmaceutical industry acquisitions by looking at the... Herzfeld, Jeffrey D. // Employee Benefits Journal;Mar1995, Vol. 20 Issue 1, p20 

    Resolves the ramifications of pharmaceutical industry acquisitions by reviewing the pharmacy benefit management firms (PBMs). Acquisition of PBMs by drug manufacturers; Disease management; Operational modes of PBMs; Management of cost of prescription drugs; Effect of legislation on PBMs and...

  • Drug wholesaler buys rival.  // Drug Topics;7/21/97, Vol. 141 Issue 14, p8 

    Reports that Neuman Health Services company acquired the Drug Guild Distributors company. Background information on both companies; Benefits of the acquisition to Drug Guild.

  • Wholesaler mergers may be conditional.  // Drug Topics;2/16/98, Vol. 124 Issue 4, p7 

    Focuses on modifications to be made to two proposed megamergers in the wholesale drug industry in the United States. Identification of the companies proposing the mergers; Percentage of the market the merged companies will control; Reference to federal approval of these proposed mergers.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics